Imvax Advances a New Approach to Personalized Cancer Immunotherapy
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
**Sponsored Content**
Learn more about Imvax’s Phase 2b trial studying a personalized, whole tumor-derived immunotherapy in newly diagnosed patients with glioblastoma.
**Sponsored Content**
See how Mary is defying the odds years after her initial glioblastoma diagnosis and how she found peace of mind through GammaTile Therapy, a one-time, targeted radiation treatment.
Kaitlin Stitz is awarded for her research on overcoming radioresistance in treatment of high risk pediatric tumors, which she conducted during her ABTA Medical Student Summer Fellowship.
American Brain Tumor Association
8550 W. Bryn Mawr Ave. Ste 550
Chicago, IL 60631
